FDA asks Lilly for more safety data on weight loss pill Foundayo

The Food and Drug Administration is asking Eli Lilly to gather more safety data on its new weight loss pill, Foundayo, including whether it could be linked to liver and heart problems, according to the approval letter published online Tuesday

Go to News Site